News · Celsius Holdings, Inc. (CELH) · Consumer Defensive

Celsius falls after securities class action filings weigh on stock

Session of October 21, 2026 · Published October 22, 2026 · 3 min read

What happened

Celsius (CELH) fell 5.5% to close at $28.31 on October 21, 2026, after multiple plaintiff law firms filed securities class action complaints, according to GlobeNewsWire and GuruFocus. Trading volume was 1.1 times its 20-day average, and the stock opened 0.3% below the previous close. The S&P 500 rose 0.6% on the day while the Consumer Defensive sector median fell 1.0%, leaving Celsius 4.5 percentage points worse than its sector median. Market commentary and the filings linked to an upcoming lead-plaintiff deadline appeared to prompt company-specific selling.

$27.00$28.00$29.00$30.00Sep 10Sep 21Sep 30Oct 12Oct 21CELH closing price, last 30 sessionspromtfinance.com$28.31 (-5.5%)
Closing price over the last 30 trading sessions. On October 21, 2026, CELH closed at $28.31, down 5.5% on the day and 6.3% higher than 30 sessions earlier.

How big was the move

The session represented 1.2 times a typical daily move for this stock, making it a large session relative to its own history. Market sensitivity is moderate, with a beta of 0.81, meaning the stock tends to move less than the market. Over the last five sessions Celsius has risen 4.2%, in contrast to the one-day drop, while the S&P 500 rose 0.5% over the same five-session span. That divergence underscores the largely company-specific nature of the decline rather than broad market weakness.

-20%0%+20%Jul 29Aug 26Sep 23Oct 21CELH daily moves, last 60 sessions2 std. dev. bandpromtfinance.com
Each bar is one day's price change; the outlined bar is October 21, 2026. A typical daily move over the past year was 3.9%, so the latest move equals 1.4 times that. Moves outside the dashed lines (about 7.8%) are unusual.

The technical picture

Technically, the stock was 1.3% above its 20-day moving average but 3.6% below its 50-day moving average and 19.9% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. Its Relative Strength Index (14 days) stood at 49, which is in a neutral range between 30 and 70. Celsius was 56.8% below its 52-week high; one-month change fell 3.7% while the three-month change rose 4.2%. Volatility remained elevated, with 60-day volatility at 71%, higher than 71% of its own readings over five years.

$40.00$60.00Oct '25Jan '26Apr '26Jul '26Oct '26CELH one-year price and moving averages200-day50-dayPricepromtfinance.com52-week high $63.4052-week low $23.77
Closing price over the past year. CELH ends the period 55.3% below its 52-week high, below its 50-day average ($29.37) and below its 200-day average ($35.35).

Fundamentals and valuation

For the four quarters through June 30, 2026, revenue was $3.05 billion, which grew 82.9% from a year earlier. Diluted earnings per share were $0.21, with earnings per share growth from a year earlier that fell 39.6%. Gross margin was 48.8%, down from 50.5% a year earlier, and operating margin was 7.9% versus 10.4% a year earlier. Free-cash-flow margin was 15.2% and return on invested capital was 5.3%. The balance sheet showed net debt of 0.2 times EBITDA and share count over one year increased by 8.3%.

$0.00$250M$500M$750MQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26CELH quarterly revenuepromtfinance.com$266M$332M$329M$739M$725M$722M$783M$818M
Quarterly revenue by period end. The latest quarter brought $818M, 10.6% more than the same quarter a year earlier.

Valuation measures remain elevated. Price to trailing earnings was 134.8 times trailing earnings, higher than 56% of its own readings over the past five years where the five-year median was 116.3 times earnings. Price to forward earnings was 19.8 times expected earnings and free-cash-flow yield was 6.5%. Within the sector, PromtFinance scores rank Growth at 77 and Quality at 83, while Value scored 25 and Stability scored 23. Those mixed scores show the market prices significant growth and quality while penalizing value and stability metrics.

Earnings and analyst expectations

Celsius last reported on August 6, 2026, delivering earnings per share of $0.36 against $0.41 expected, which was 13.0% below estimates. The stock has recorded zero consecutive quarters beating estimates, though average surprise over the last four reports was 29.8% above estimates. Typical two-day reaction after recent reports was that the stock fell 2.2%. Analysts covering the stock number 25, with 88% assigning a rating of Buy or Strong Buy and a consensus rating of Buy. The consensus price target is $41.38, which is 46.2% above the closing price. The next earnings report is scheduled for November 5, 2026.

-$0.20$0.00$0.20Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26CELH quarterly earnings per sharepromtfinance.com-$0.00-$0.13$0.15$0.33-$0.30$0.04$0.33$0.14
Diluted earnings per share by quarter. The latest quarter shows $0.14, against $0.33 in the same quarter a year earlier.

What to watch

  • November 3, 2026: lead plaintiff/deadline for the securities class action filings, as notified by law firms (GlobeNewsWire, GuruFocus)
  • November 5, 2026: next earnings report date
  • Consensus price target of $41.38 relative to the closing price
  • Trading volume relative to its 20-day average and any further legal developments reported by major outlets

Related stocks

More news from PromtFinance

Related stories from the last 48 hours

LRNConsumer DefensiveOct 21Stride falls 3.2% after disappointing enrollment tied to platform issuesStride (LRN) fell 3.2% to $76.39 on October 21, 2026, after quarterly results showed enrollment disruption from technology issues.Read the analysis →MRPReal EstateOct 20Millrose Properties rises 6.7% after securities class action notices are announcedMillrose Properties rose 6.7% on October 20, 2026, as notices of securities class action litigation were reported, ahead of an earnings date on October 22, 2026.Read the analysis →RCUSHealthcareOct 21Arcus Biosciences falls 19.6% after $250 million share offeringArcus Biosciences fell 19.6% on October 21, 2026, after launching a $250 million underwritten share offering and amid a securities probe.Read the analysis →CMGConsumer CyclicalOct 21Chipotle falls 5.2% after Wall Street trims outlooksChipotle fell 5.2% to $28.12 on October 21, 2026, after analysts cut forecasts ahead of its October 28 earnings report.Read the analysis →RAILIndustrialsOct 20FreightCar America falls 31.5% after it removes 1,285‑car retrofit order from outlookFreightCar America plunged 31.5% on October 20, 2026, after it removed a 1,285‑car tank retrofit order from its 2026 outlook and disclosed securities‑fraud probes.Read the analysis →WELLReal EstateOct 21Welltower falls 1.6% after occupancy news and ahead of earningsWelltower fell 1.6% on Oct. 21, 2026, as occupancy reports and a dividend increase coincided with the stock’s slip ahead of earnings.Read the analysis →WDFCBasic MaterialsOct 21WD-40 falls 4.4% after quarterly EPS misses estimates because of weaker profitWD-40 fell 4.4% on October 21, 2026, after quarterly EPS missed estimates; revenue rose 11% for fiscal 2026.Read the analysis →